01.03.2022
Acino condemns the military actions in Ukraine
“I would like to express my deepest sadness and horror about the unfolding tragic events in Ukraine. Our thoughts and...
News
01.03.2022
Acino completes acquisition of Aspen brands
Acino completes acquisition of selected trusted Aspen brands, bringing additional investment into the South African Healthcare sector. ZURICH, Switzerland, 1...
18.02.2022
Acino and Ferrer sign distribution agreement
Acino will commercialize several Ferrer products in the fields of neurology, urology and treatment of respiratory disorders in the Republic...
13.01.2022
Meet Ayad Jassim, Site Quality Head
Dedication and expertise are key qualities necessary to provide flexible solutions to our customers, and we are lucky to have...
12.01.2022
Acino gathers UAE’s leading experts on cardiovascular disease to build awareness and inspire solutions
Thought-leader summit lauded as a vital effort to tackle Middle East’s rising CVD-associated mortality rates. 12 January 2022; Dubai, United...
13.12.2021
“Mental health for everyone, everywhere” – Acino META includes mental health awareness in its broader wellness strategy
According to The Lighthouse Center for Wellbeing, “Mental Health First Aid (MHFA) equips individuals and organisations with the skills to...
28.10.2021
Acino wins Product of the Year at the Panacea awards, Ukraine’s most prestigious pharmaceutical industry accolade
The award went to one of Acino’s antipsychotic medicines. The product is manufactured at Pharma Start, Acino’s pharmaceutical plant in...
26.10.2021
Acino wins CSR Project of the Year and Regulatory Affairs Director of the Year at Eurasian Pharma Awards
Acino has won two Eurasian Pharma Awards in the categories of Corporate Social Responsibility Project of the Year, and Regulatory...
22.10.2021
Acino acquires selected Aspen brands in South Africa
ZURICH, Switzerland, 22 October 2021 – Acino and Aspen Pharmacare Holdings Limited and its subsidiaries (collectively, “Aspen”) have signed an...